Nexium | Nexium News | Nexium Photos

Web Sify

Sify.com » Topics » Nexium

Nexium News

Ranbaxy beats forecast as Q3 profit jumps

Can Ranbaxy recover from its US debacle?
"We are pleased to have resolved this legacy issue with the FDA as we begin the next chapter in Ranbaxy's history," stated Arun Sawhney, CEO & Managing Director of India's biggest drug-maker Ranbaxy few weeks ago. Sawhney's announcement came on December 21, after Ranbaxy signed a consent decree with the US Food and Drugs Administration (USFDA)-the body that green lights the entry of all drugs into

Share market, analysts give Ranbaxy a thumbs down

Lack of clarity over the extent of damage that awaits Ranbaxy if it fails to clear its ongoing American regulatory troubles in a time-bound manner took a heavy toll on its share prices on Friday. The

more

Why drugs have tongue-twisting names
The tongue-twisting generic names assigned to drugs are products of 'stems' that describe everything from a drugs' function to its shape, a new study has revealed.

more

Drugmaker AstraZeneca to cut 1,150 US employees
AstraZeneca PLC will cut roughly 24 percent of its U.S. sales force in a push to curb costs as the drugmaker fends off growing generic challenges.

more

Drugmaker AstraZeneca to cut 1,150 US employees
AstraZeneca PLC will cut roughly 24 percent of its U.S. sales force in a push to curb costs as the drugmaker fends off growing generic challenges.

more

FDA overhang persists

While Lipitor generic launch will drive Ranbaxy’s revenues in 2012, the resolution of FDA issues is key trigger for the stock. The Ranbaxy management last week stated that launch of the

more

1 2 3 Next »

Most Searched

ek main aur ekk tu pnr status enquiry esha deol espn live afmc yuvraj mahindra xylo bangladesh premier league australia vs sri lanka valentine day sms agent vinod promise